Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ingested (oral) adrenocorticotropic hormone (ACTH) inhibits interleukin-17 in the central nervous system after adoptive transfer of T helper (Th)1/Th17 T cells in the mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis.

Journal of the neurological sciences·2023
Same author

The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica.

Autoimmunity reviews·2022
Same author

Ingested (Oral) Adrenocorticotropic Hormone Inhibits IL-17 in the Central Nervous System in the Mouse Model of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

ImmunoHorizons·2022
Same author

Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease.

Journal of Alzheimer's disease : JAD·2021
Same author

Immune reconstitution therapy in NMOSD.

Multiple sclerosis and related disorders·2021
Same author

Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects.

Multiple sclerosis and related disorders·2020

Related Experiment Video

Updated: Oct 23, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

A proposal: How to study pro-myelinating proteins in MS.

Staley A Brod1

  • 1Department of Neurology, Medical College of Wisconsin, Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI 53226, United States of America.

Autoimmunity Reviews
|August 20, 2021
PubMed
Summary

This study explores promoting repair in multiple sclerosis (MS) by monitoring myelin regeneration. Linking pro-myelinating proteins to imaging changes could enable new therapies for CNS repair.

Keywords:
BDNFMWFMultiple sclerosisNCAMQSM

More Related Videos

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.0K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.3K

Related Experiment Videos

Last Updated: Oct 23, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.0K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.3K

Area of Science:

  • Neuroscience
  • Immunology
  • Radiology

Background:

  • Multiple sclerosis (MS) is a central nervous system (CNS) disease causing inflammation and degeneration.
  • A key challenge in MS is promoting endogenous repair, specifically remyelination, to preserve neurons and prevent disease progression.

Purpose of the Study:

  • To investigate methods for monitoring in vivo remyelination in MS patients.
  • To link changes in pro-myelinating proteins with imaging markers of myelin repair.

Main Methods:

  • Utilizing advanced MRI techniques like quantitative susceptibility mapping (QSM) and myelin water imaging (MWI).
  • Monitoring MS lesions with gadolinium enhancement (Gd+) to capture the acute inflammatory phase and subsequent remyelination.
  • Analyzing blood and cerebrospinal fluid (CSF) for pro-myelinating protein levels (e.g., N-CAM, BDNF).

Main Results:

  • Evidence suggests histological repair and remyelination occur in MS patients.
  • Non-conventional MRI techniques can detect changes associated with acute remyelination.
  • The period following acute inflammation in MS lesions presents an optimal window for monitoring repair.

Conclusions:

  • Monitoring pro-myelinating proteins alongside advanced MRI in MS lesions can reveal links between protein levels and myelin formation.
  • This approach may pave the way for therapeutic strategies involving direct administration of proteins to promote CNS remyelination.